Overview of Finpecia Research Compound
Finpecia is a 5α-reductase inhibitor pharmaceutical manufactured by Cipla containing 1mg finasteride per tablet. This FDA-approved compound serves as an established reference standard in laboratory investigations examining dihydrotestosterone (DHT) synthesis pathways. Finasteride represents a synthetic 4-azasteroid that competitively inhibits the 5α-reductase enzyme, specifically the type II isoform responsible for converting testosterone to dihydrotestosterone in target tissues. Research protocols examining androgen metabolism frequently incorporate this well-characterised inhibitor due to its documented mechanism of action and extensive clinical literature. Laboratory studies investigating hormonal cascades benefit from Stroid UK Shop providing pharmaceutical-grade reference compounds for reproducible experimental conditions.
Laboratory Research Applications
Research teams studying androgenic pathways utilise Finpecia to investigate 5α-reductase enzyme kinetics and DHT-dependent cellular responses. The compound demonstrates selective inhibition of 5α-reductase type II with IC50 values documented in published literature, making it valuable for dose-response studies in cell culture systems. Investigations examining prostate tissue biology frequently employ finasteride as a tool compound to elucidate DHT-mediated gene expression changes. Comparative studies with other aromatase inhibitors and finasteride compounds enable researchers to distinguish between different hormonal inhibition pathways. Additionally, metabolic research examining steroidogenesis pathways benefits from this selective enzyme inhibitor alongside SARM research compounds for comprehensive androgen receptor studies.
Technical Specifications
| Active Compound | Finasteride |
|---|---|
| Manufacturer | Cipla Pharmaceuticals |
| Dosage Form | 1mg film-coated tablets |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.55 g/mol |
| Storage Requirements | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Laboratory Storage and Handling
Maintain Finpecia tablets in original pharmaceutical packaging at controlled room temperature between 15-30°C, protected from moisture and direct sunlight. The film-coated formulation provides stability under standard laboratory conditions, with manufacturer documentation indicating multi-year shelf life when stored appropriately. Research protocols should incorporate proper handling procedures for pharmaceutical-grade reference standards, including documentation of storage conditions and expiration monitoring. Studies examining steroid metabolism alongside peptide research compounds require consistent environmental controls to maintain compound integrity throughout experimental timelines.
Important: This product is strictly intended for in-vitro laboratory research purposes only. Not approved for human consumption or therapeutic use. Researchers must comply with institutional guidelines and applicable regulations governing research chemical handling and storage protocols.
